References

• Steven R. Devore Best, MD (2026). A Network-Based Approach to Depression, Neuropathic Pain, and Substance Use Disorder Using Coadministered TMS and Ketamine Psychiatric Times, Vol 43, Issue 1, p 31-32
• Steven R. Devore Best, MD (2025). Combination Therapy With TMS and Ketamine for Depression, Neuropathic Pain, and Substance Use Disorder: A Network-Based Approach Psychiatric Times, 5 November 2025
• Steven R. Devore Best, MD (2025). Contribution of Genetics, Environment, and Inflammation to Development of Severe Mental Illness. Psychiatric Times, 3 September 2025
• Steven R. Devore Best, MD, Dan Pavel, MD (2025). What’s Perfusion Got to Do With It?. Psychiatric Times,12 May 2025
• Best, S. R., Haustrup, N., & Pavel, D. G. (2022). Brain SPECT as an Imaging Biomarker for Evaluating Effects of Novel Treatments in Psychiatry–A Case Series. Frontiers in Psychiatry, January 2022 | Volume 12 | Article 713141.
• Best, S. R., Pavel, D. G., & Haustrup, N. (2019). Combination therapy with transcranial magnetic stimulation and ketamine for treatment-resistant depression: A long-term retrospective review of clinical use. Heliyon, 5(8), e02187.
• Best, S., & Pavel D.G. (2019.) Clinical Use of Combined Transcranial Magnetic Stimulation with Intravenous Ketamine for Treatment-Resistant Depression with Comorbid Pain, Substance Misuse, and Grief: A Case Report Current Opinions in Neurological Science 3.2: 672-677
• Best, S., & Pavel, D. G. (2017). Combined transcranial magnetic stimulation and ketamine for treatment of refractory mood disorder, anxiety, and pain: A case report. Current Neurobiology, 8(1),
• Pavel, D., & Best, S. (2017). Brain SPECT as Imaging Biomarker for Evaluating Effects of Novel Treatments in Psychiatry. Journal of Nuclear Medicine, 58(supplement 1), 1298-1298.
• Best, S., & Pavel, D. G. (2017). Treatment of post-anesthesia dementia with perispinal etanercept injection and hyperbaric oxygen therapy: a case report. Journal of medical case reports, 11(1), 1-4. (Top 25 Clinical Case Reports (2018)
• Best, S., & Pavel, D. G. (2017). Combined transcranial magnetic stimulation and ketamine for treatment of refractory mood disorder, anxiety, and pain: A case report. Current Neurobiology, 8(1), 1-4.
• Best, S., & Pavel, D. G. (2016). Effective Stepwise Anti-inflammatory Treatment for Markedly Disabling Neuropsychiatric Comorbidities: A Case Report. J Neurol Neurosci, 7, 4.
• Elkrief, L., Payette, O., Foucault, J. N., Longpré-Poirier, C., Richard, M., Desbeaumes Jodoin, V., Lespérance, P., & Miron, J. P. (2022). Transcranial magnetic stimulation and intravenous ketamine combination therapy for treatment-resistant bipolar depression: A case report. Frontiers in psychiatry, 13, 986378. https://doi.org/10.3389/fpsyt.2022.986378
• Dębowska, W., Więdłocha, M., Dębowska, M., Kownacka, Z., Marcinowicz, P., & Szulc, A. (2023). Transcranial magnetic stimulation and ketamine: implications for combined treatment in depression. Frontiers in neuroscience, 17, 1267647. https://doi.org/10.3389/fnins.2023.1267647
• Jiang, W., Isenhart, R., Sutherland, R., Lu, Z., Xu, H., Pace, J., Bonaguidi, M. A., Lee, D. J., Liu, C. Y., & Song, D. (2022). Subthreshold repetitive transcranial magnetic stimulation suppresses ketamine-induced poly population spikes in rat sensorimotor cortex. Frontiers in neuroscience, 16, 998704. https://doi.org/10.3389/fnins.2022.998704
• Ramakrishnan, N., Murphy, N. R. E., Walker, C. P., Cuellar Leal, V. A., Soares, J. C., Cho, R. Y. J., & Selvaraj, S. (2019). Neurophysiological Effect of Ketamine on Prefrontal Cortex in Treatment-Resistant Depression: A Combined Transcranial Magnetic Stimulation-Electroencephalography Study. Chronic stress (Thousand Oaks, Calif.), 3, 2470547019861417. https://doi.org/10.1177/2470547019861417
• Arubuolawe, O. O., Folorunsho, I. L., Busari, A. K., Ibeneme, C., Diala, A. B., Afolabi, V. I., Harry, N. M., Anona, K., Obitulata-Ugwu, V. O., Kuye, O. A., & Anugwom, G. O. (2024). Combination of Transcranial Magnetic Stimulation and Ketamine in Treatment-Resistant Depression: A Systematic Review. Cureus, 16(7), e64712. https://doi.org/10.7759/cureus.64712
• Carter, M., Solsrud, K., & Mischel, N. (2022). Case report: Intranasal esketamine for severe major depressive disorder with psychotic features. Frontiers in psychiatry, 13, 937996. https://doi.org/10.3389/fpsyt.2022.937996
• Sommers, K. (2025). Concurrent transcranial magnetic stimulation and ketamine therapy: Case report. American Journal of Psychiatry Residents' Journal, 20(4), 9–11. https://doi.org/10.1176/appi.ajp-rj.2025.200404